Conditions: Osteoarthritis
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 600
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the safety of Meloxicam SoluMatrix Capsules for up to 52 weeks in subjects with pain due to osteoarthritis (OA) of the knee or hip

Detailed description:

Arms:
arm 1: One Capsule QD

Interventions: intervention 1: Meloxicam Test Capsules
Intervention descriptions: intervention 1: None

Protocol document: